Correcting temperature-sensitive protein folding defects

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Protein folding defects are implicated in various human diseases.
• Temperature-sensitive protein mutants exhibit misfolding at elevated temperatures.
• Previous work demonstrated that small molecules can correct deltaF508 cystic fibrosis transmembrane regulator (CFTR) protein defects.

Purpose of the Study:

• To investigate if protein stabilizing agents can correct temperature-sensitive folding defects in other proteins.
• To determine the general applicability of using small molecules to rescue protein misfolding in vivo.
• To explore a potential therapeutic strategy for protein misfolding diseases.

Main Methods:

• Utilized cell lines expressing temperature-sensitive mutants of p53, pp60src, and ubiquitin-activating enzyme E1.
• Incubated cells at a non-permissive temperature (39.5°C) in the presence of stabilizing compounds like glycerol, trimethylamine N-oxide, and deuterated water.
• Assessed cellular phenotypes to evaluate the correction of protein folding defects.

Main Results:

• Incubation with stabilizing agents at the non-permissive temperature rescued the cellular phenotypes associated with protein folding defects.
• The observed rescue was comparable to phenotypes at the permissive temperature (32.5°C).
• Demonstrated successful correction of folding defects for multiple temperature-sensitive proteins.

Conclusions:

• Protein stabilizing agents are effective in correcting protein folding abnormalities in vivo.
• This strategy holds potential for therapeutic intervention in human diseases characterized by protein misfolding.
• The findings support a broad application of small molecules for managing proteinopathies.